Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Katarzyna Betkier‐Lipińska"'
Autor:
Maria Wieteska‐Miłek, Beata Kuśmierczyk‐Droszcz, Katarzyna Betkier‐Lipińska, Sebastian Szmit, Michał Florczyk, Piotr Zieliński, Piotr Hoffman, Paweł Krzesiński, Marcin Kurzyna
Publikováno v:
Pulmonary Circulation, Vol 13, Iss 2, Pp n/a-n/a (2023)
Abstract Pulmonary arterial hypertension (PAH) and chronic thromboembolic pulmonary hypertension (CTEPH) patients have a more severe COVID‐19 course than the general population. Many patients report different persistent symptoms after SARS‐CoV‐
Externí odkaz:
https://doaj.org/article/806d114a472040fe9737a05e915015c6
Autor:
Maria, Wieteska-Miłek, Beata, Kuśmierczyk-Droszcz, Robert, Ryczek, Sebastian, Szmit, Michał, Florczyk, Rafał, Mańczak, Katarzyna, Betkier-Lipińska, Piotr, Hoffman, Paweł, Krzesiński, Adam, Torbicki, Marcin, Kurzyna
Publikováno v:
Polish Archives of Internal Medicine.
Pulmonary arterial hypertension (PAH) and chronic thromboembolic pulmonary hypertension (CTEPH) lead to progressive right heart failure. The mortality rates of PAH and CTEPH due to the coronavirus disease (COVID-19) are high, and vaccination against
Autor:
Grzegorz Suwalski, Piotr Hendzel, Katarzyna Betkier-Lipińska, Andrzej Cwetsch, Sebastian Czarkowski
Publikováno v:
Kardiochirurgia i Torakochirurgia Polska = Polish Journal of Cardio-Thoracic Surgery
Idiopathic dilatation of the pulmonary artery (IDPA) is a rare congenital heart disease. It has been described for almost one hundred years, and numerous definitions have been proposed. The IDPA diagnostic criteria have not been updated for years. Se
Publikováno v:
Polski merkuriusz lekarski : organ Polskiego Towarzystwa Lekarskiego. 38(223)
Pulmonary arterial hypertension (PAH) is a chronic, serious disease caused by remodeling of small pulmonary vessels, which leads to increase of pulmonary resistance, right heart failure and death. The 1990ths of XX century are the beginning of dynami
Publikováno v:
Polski merkuriusz lekarski : organ Polskiego Towarzystwa Lekarskiego. 37(222)
Recent years are the time of dynamic development of pulmonary arterial pressure pharmacotherapy. By introducing the goal oriented therapy the survival in this group of patients has significantly increased. Apart from the pharmacotherapy used accordin
Publikováno v:
Polski merkuriusz lekarski : organ Polskiego Towarzystwa Lekarskiego. 34(204)
Pulmonary arterial hypertension (PAH) belongs to the group of rare diseases and the morbidity rate is 15 to 50 people per million per year. Before the era of specific treatment of PAH, the prognosis was poor. The average life expectancy of the patien
Publikováno v:
Polski merkuriusz lekarski : organ Polskiego Towarzystwa Lekarskiego. 34(204)
Pulmonary hypertension may be associated with many clinical conditions, including connective tissue diseases. We present a case of a patient with sclerodermia and chronic myeloid leukemia, who developed severe symptoms of pulmonary hypertension. Atyp